Interv Akut Kardiol. 2016;15(1):26-32 | DOI: 10.36290/kar.2016.005
Significant mitral regurgitation (MR) is a severe disease affecting around 10 % of people above the age of 75 years, and/or with
left ventricular dysfunction, often associated with severe symptoms of heart failure and reduced survival. While surgery remains
the treatment method of choice in low-risk patients with degenerative type of disease, in high-risk patients with functional MR
transcatheter procedure with the MitraClip System is emerging as a safe and effective alternative therapeutic option. Besides this,
several devices, addressing many different anatomical structures of the mitral valve, are under development.
Published: February 1, 2016 Show citation